Targeted genetic testing with the Invitae primary immunodeficiency panel revealed two heterozygous VUS, that is, in DOCK8 (C.277G>T, p.Val93Leu) and FOXN1 (c.1205del, p.Pro402Leufs*148). This evidence concerns the gene DOCK8 and inborn error of immunity.